{"latest_checked": "2026-07-29T22:11:07.860409+00:00", "coverage_count": 5079, "recent_count": 8, "transaction_limit": 160, "filters": {"q": "", "ticker": "BTAI", "sector": "", "industry": "", "side": "", "start": "2026-06-15", "end": "2026-07-30"}, "summary": {"total": 8, "acquisition_count": 4, "disposal_count": 4, "acquisition_value": 0.0, "acquisition_value_label": "$0", "disposal_value": 0.0, "disposal_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "flow_tone": "neutral", "largest_value_label": "$0", "top_sector": "Healthcare", "window_label": "15 Jun 2026 to 30 Jul 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 8, "value": "0.0000", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$0"}], "days": [{"transaction_date": "2026-06-15", "acquisitions": 4, "disposals": 4, "total": 8, "bar_width": 100.0}], "side_mix": {"acquisitions": 4, "disposals": 4, "acquisition_share": 50.0, "disposal_share": 50.0}}, "company_flows": [{"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-06-15", "acquisitions": 0, "disposals": 4, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 0.0, "disposal_share": 100.0, "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}], "company_overview": [{"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/drug-manufacturers-specialty-generic/", "latest_transaction": "2026-06-15", "filings": 8, "acquisitions": 4, "disposals": 4, "acquired_value": 0.0, "acquired_value_label": "$0", "disposed_value": 0.0, "disposed_value_label": "$0", "net_value": 0.0, "net_value_label": "$0", "acquisition_share": 50.0, "disposal_share": 50.0, "tone": "Mixed flow", "tone_class": "neutral", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}], "transactions": [{"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-15", "executive": "MEHTA, VIMAL", "executive_title": "Director, CEO and President", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 219.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-14T11:03:33.555298+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}, {"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-15", "executive": "RODRIGUEZ, JAVIER", "executive_title": "See Remarks", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 35.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-14T11:03:33.548083+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}, {"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-15", "executive": "STEINHART, RICHARD I", "executive_title": "Chief Financial Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 35.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-14T11:03:33.536860+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}, {"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-15", "executive": "YOCCA, FRANK", "executive_title": "Chief Scientific Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 35.0, "share_price": null, "transaction_value": null, "fetched_at": "2026-07-14T11:03:33.553690+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}, {"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-15", "executive": "MEHTA, VIMAL", "executive_title": "Director, CEO and President", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 219.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:03:33.550339+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}, {"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-15", "executive": "RODRIGUEZ, JAVIER", "executive_title": "See Remarks", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 35.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:03:33.545080+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}, {"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-15", "executive": "STEINHART, RICHARD I", "executive_title": "Chief Financial Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 35.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:03:33.556987+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}, {"symbol": "BTAI", "name": "BioXcel Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic", "transaction_date": "2026-06-15", "executive": "YOCCA, FRANK", "executive_title": "Chief Scientific Officer", "security_type": "Restricted Stock Units", "side_code": "D", "side": "Disposal", "shares": 35.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T11:03:33.552146+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/btai/", "research_links": {"chart": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/", "report": "/terminal/9de26ac3-ef1e-4317-b207-b26df479107e/report/", "factor": "/factors/ticker/9de26ac3-ef1e-4317-b207-b26df479107e/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}